Measuring microglial activity using soluble markers has gained interest in the field of AD biomarker identification, where Triggering receptor expressed on myeloid cells 2 (TREM2) and Galectin-3 (Gal-3) are the most studied soluble markers. Here, LGALS3 is linked to Alzheimer disease.